Diabetes educators can help patients with diabetes who face financial challenges make appropriate choices and receive assistance to afford medications, said Kellie Rodriguez, RN, MSN, MBA, CDE, director, Global Diabetes Program, Parkland Health & Hospital System.
Diabetes educators can help patients with diabetes who face financial challenges make appropriate choices and receive assistance to afford medications, said Kellie Rodriguez, RN, MSN, MBA, CDE, director, Global Diabetes Program, Parkland Health & Hospital System.
What are some of the challenges diabetes educators anticipate as patients are asked to assume more financial responsibility for their care?
It’s a real privilege to be a diabetes educator. We really get to immerse ourselves in the lived world of the patient and the person living with diabetes. And with that comes a real responsibility. So, the self-care requirements—it’s a disease of self-care—the self-care requirements are extensive and they’re daily and they’re unrelenting. So, all the lifestyle requirements, the monitoring, the medication requirements, the visit requirements are all very costly, and so, what it does require us to do is start to think a little bit more creatively around prioritizing care and looking for strategies and solutions that may be less costly. Or being able to adapt our recommendations to the lived world of the patient.
So, if finances are a challenge and they’re living from the dollar menu, we need to be able to accommodate that and not say, “That’s not appropriate,” but look for appropriate choices in those sorts of areas. Same with medications, looking for prescription assistance programs to support some of the needs for people to be able to achieve the medications that they have. So, there’s a lot of different strategies that we need to be mindful of.
I think the key is to be able to assess it first and to recognize it’s a problem. And I think in healthcare we’re doing a better job of moving away from just clinical assessment to more of the lived world assessment to be able to better understand that’s a concern and be sure that we incorporate that in all of our strategies including pharmacotherapy choices. Sometimes the best pharmacotherapy choice may not be the best patient choice, but we’re going to make the best patient choice, because that’s what’s going to lead to the best outcomes.
BCI Shows Promise of Personalized Endocrine Therapy in Breast Cancer
January 15th 2025The Breast Cancer Index (BCI) may help identify patients with low-risk breast cancer who could potentially benefit from reduced endocrine therapy, leading to improved quality of life and potentially lower health care costs.
Read More
Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL
December 26th 2024A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.
Listen
Designing Care for the Underserved Creates Higher-Value Health Solutions
January 12th 2025In the second half of our interview with Brita Roy, MD, MPH, MHS, NYU Grossman School of Medicine, she discusses effective engagement of minoritized populations in discussion of medical mistrust.
Read More
AI's Role in Oncology: Supporting, Not Replacing, Health Care Providers
January 9th 2025In this second half of our interview with Vanderbilt University Medical Center’s Travis Osterman, DO, MS, FAMIA, FASCO, he discusses opportunities for advancing the smart use of artificial intelligence (AI) in cancer care.
Read More